Nocturnal asthma and the use of theophylline

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 3, 1998, Pages 64-70

  Martin, R J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; THEOPHYLLINE;

AMINO ACID SUBSTITUTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHODILATATION; CHOLINERGIC SYSTEM; CHRONOTHERAPY; DNA POLYMORPHISM; DRUG EFFICACY; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; THEOPHYLLINE BLOOD LEVEL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIAL PROVOCATION TESTS; BRONCHODILATOR AGENTS; CIRCADIAN RHYTHM; GLYCINE; HUMANS; NEUROBEHAVIORAL MANIFESTATIONS; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATORY FUNCTION TESTS; THEOPHYLLINE; TIME FACTORS;

EID: 0031904027     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Floyer JA. treatise on asthma. In: London: Witkin, J and Inngs W., 1698, 7-8.
2. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85 (Suppl. 1B):6-8.
3. Heztel MR, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35:732-8.
4. Martin RJ, Cicutto LC, Ballard RD. Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis 1990; 141:33-8.
5. Ballard RD, Saathoff MC, Patel DK, Kelly PL, Martin RJ. Effect of sleep on nocturnal bronchoconstriction and ventilatory patterns in asthmatics. J Appl Physiol 1989; 67:243-9.
6. Barnes P, FitzGerald G, Brown M et al. Nocturnal asthma and changes in circulatory epinephrine, histamine and cortisol. N Engl J Med 1980; 303:263-7.
7. Postma DS, Keyzer JJ, L.êterm HG et al. Influence of the parasympathetic and sympathetic nervous system on nocturnal bronchial obstruction. Clin Sci 1985; 69:251-8.
8. Brooks SM, McGowan K, Bernstein IL et al. Relationship between numbers of beta-adrenergic receptors in lymphocytes and disease severity in asthma. J Allergy Clin Immunol. 1979; 63:401-6.
9. Smolensky MH, DíAlonzo GE. Nocturnal asthma: Mechanisms and chronotherapy. In: Touitou Y, Haus E, eds Biological Rhythms in Clinical and Laboratory Medicine. New York: Springer-Verlag 1992:453-469.
10. Szefler SJ, Ando R, Cicutto LC et al. Plasma histamine, epinephrine, cortisol, and leukocyte β-adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther 1991; 49:59.
11. Turki J, Pak J, Green SA et al. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal asthma: evidence that Gly16 correlates with nocturnal phenotype. J Clin Invest 1995; 95:1635-41.
12. Morrison JFJ, Pearson SB, Dean HG. Parasympathetic nervous system in nocturnal asthma. Br Med J 1988; 296:1427-9.
13. Kallenbach JM, Webste T, Dowdeswell R et al. Reflex heart rate control in asthma: Evidence of parasympathetic over activity. Chest 1985; 5:644-7.
14. Bousguet J, Chavez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033-9.
15. Martin RJ, Cicutto LC, Ballard RD, Smith HR, Szefler SJ. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991; 143:351-7.
16. Dahl R. Diurnal variation in the number of circulatory eosinophil leukocytes in normal controls and asthmatics. Acta Allergologics 1977; 32:301-3.
17. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17.
18. Dunnill MS. The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1960; 13:27-33.
19. Laitinen LA, Heino M, Laitinen A et al. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985; 121:599-606.
20. Corrigan CJ, Kay A. Activated T-lymphocytes in acute and severe asthma: A primary target for both new and conventional asthma therapy. Immunol Allergy 1990; 12:209-15.
21. Wenzel SE, Trudeau JB, Kaminsky DA, Cohn J, Martin RJ. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152:897-905.
22. Mohiuddin AA, Martin RJ. Circadian basis of the late asthmatic response. Am Rev Respir Dis 1990; 142:1153-7.
23. Kuehl FA Jr, Zanetti ME, Soderman DD, Miller DK, Ham EA. Cyclic AMP-dependent regulation of lipid mediators in white cells; a unifying concept for explaining the efficacy of theophylline in asthma. Am Rev Respir Dis 1987; 136:210-3.
24. Dent G, Magnussen H, Rabe KF. Cyclic nucleotide phosphodiesterasesin the human lung. Lung 1994; 172:129-46.
25. Belvisi MG, Miura M, Peters MJ et al. Effect of isoenzyme - selective cyclic nucleotide phosphodiesterase inhibitors on human smooth muscle tone. Br J Pharmacol 1992; 107:53p.
26. deBoer J, Philpott AJ, VanAmsterdam GM, Shahid M, Zaagsma J, Nicholson CD. Human bronchial cyclic nucleotide phoshodiesterese isoenzyme. Br J Pharmacol 1993; 106:1028-34.
27. Rabe KF, Tenor H, Dent G, Nakashima M, Schudt D, Magnussen H. Effects of selective phosphodiesterase inhibitors on human pulmonary artery tone in vitro. Am Rev Respir Dis 1993; 147:A183.
28. Rabe KF, Tenor H, Dent G, Schudt C, Liebig S, Magnussen H. Phosphodiesterase isoenzymes modulating inherent tone in human airways; identification and characterization. Am J Physiol 1993; 264:L458-64.
29. Naclerio RM, Bartenfelder D, Proud D et al. Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol 1986; 78:874-6.
30. Pauwels R, VanReuterghem D, VanDer Staeton V, Johannesson N, Persson CGA. The effect of theophylline and enprofylline on allergen induced brochoconstriction. J Allergy Clin Immunol 1985; 76:583-9.
31. Booij-Noord H, DeVries K, Sluiter HJ, Orie NGM. Late bronchial obstructive reaction to experimental inhalation of house dust extract. Clin Allergy 1972; 2:43-61.
32. Kraft M, Pak J, Borish L, Martin RJ. Theophylline's effect on neutrophil funciton and the late asthmatic response. J Allergy Clin Immunol 1996; 98:251-7.
33. McDonald RJ. Pentoxifylline reduces injury to isolated lungs perfused with human neutrophils. Am Rev Respir Dis 1991; 144:1347-50.
34. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffer P, Costello J. Antiinflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994; 343:1006-8.
35. Bentley AM, Menz G, Storz CHR et al. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Am Rev Respir Dis 1992; 146:500-6.
36. Gerblich AA, Salik H, Schuyler MR. Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics. Am Rev Respir Dis 1991; 143:533-7.
37. Fink G, Mittelman M, Shohat B, Spitzer SA. Theophylline-induced alterations in cellular immunity in asthmatic patients. Clin Allergy 1987; 17:313-6.
38. Shohat B, Volovitz B, Varsano I. Induction of suppressor T-cells in asthmatic children by theophylline treatment. Clin Allergy 1983; 13:487-93.
39. Kidney JC, Dominguez M, Taylor P et al. Airway lymphocyte infiltration in asthma increases after withdrawing chronic theophylline treatment. Am J Respir Crit Care Med 1994; 149:A280.
40. Dent G, Giembycz MA, Rabe KF, Wolf B, Barnes PJ, Magnussen H. Theophylline suppresses human macrophage respiratory burst through phosphodiesterase inhibition. Am J Respir Cell Mol Biol 1994; 10:565-72.
41. Brenner M, Berkowitz R, Marshall N, Strunk RC. Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy 1988; 18:143-50.
42. Nassif EG, Weinberger M, Thompson R, Huntley W. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med 1981; 304:71-5.
43. Kraft M, Torvik JA, Trudeau JB, Wenzel SE, Martin RJ. Theophylline: potential antiinflammatory effects in nocturnal asthma. J Allergy Clin Immunol 1996; 97:1242-6.
44. Zwillich CW, Neagley SR, Cicutto L, White DP, Martin RJ. Nocturnal asthma therapy. Am Rev Respir Dis 1989; 139:470-4.
45. Martin RJ, Cicutto LC, Ballard RD, Goldenheim PD, Cherniack RM. Circadian variations in theophylline concentrations and the treatment of nocturnal asthma. Am Rev Respir Dis 1989; 139:475-8.
46. D'Alonzo GE, Smolensky MH, Feldman S et al. Twenty-four hour lung function in adult patients with asthma. Am Rev Respir Dis 1990; 142:84-90.
47. Martin RJ. Nocturnal asthma: an overview. In: Martin RJ, ed. Nocturnal Asthma: Mechanisms and Treatment. Mount Kisco, N.Y. Futura Publishing Co., Inc. 1993:71-115.